Can VR elicit SAD-typical distress? In 21 SAD adults + 24 non-anxious controls, VR public-speaking task elicited significant physiological + subjective distress over baseline - but less than the in-vivo task; no SAD-vs-control group differences on physiology
How this was rated
Within-subjects design with both SAD (n=21) and non-anxious control (n=24) groups, all completing both VR and in-vivo speech tasks. Strong physiological measurement (HR, EDA, RSA) alongside self-report distress. Peer-reviewed in Journal of Psychopathology and Behavioral Assessment (Springer, established peer-reviewed clinical-psychology venue). Limitations: VR hardware was era-appropriate research-grade (2014-2015), not contemporary consumer hardware. The null physiological finding between SAD and control groups in VR may reflect the attenuated VR response rather than true equivalence between groups - a power-and-paradigm caveat. The realism-and-validity framing is the contribution; clinical-efficacy claims are not part of this study's design.
Ratings use a simplified four-tier scheme (High, Moderate, Low, Very Low) informed by the GRADE working group. Learn more about how studies are rated.
Twenty-one adults with social anxiety disorder (SAD) and 24 non-anxious controls each gave an impromptu speech in front of an in-vivo (live) audience AND in front of a virtual reality audience. Outcomes: heart rate, electrodermal activity, respiratory sinus arrhythmia, and self-reported distress, plus sense of presence ratings. Results: VR significantly increased heart rate, electrodermal activity, RSA, and subjective distress over baseline - but less than the in-vivo task. Participants reported moderate presence in VR, but significantly less than in-vivo. NO significant SAD-vs-control group differences on physiological measures. The study addresses VR's realism-and-validity for SAD clinical work.
An important realism-and-validity study comparing VR public-speaking to in-vivo public-speaking in 21 SAD adults + 24 controls. VR DOES elicit physiological and subjective distress over baseline - a prerequisite for using VR clinically with SAD - but the response is ATTENUATED compared to in-vivo public-speaking, and presence is moderate rather than high. Critically, NO SAD-vs-control physiological differences emerged in this paradigm - a finding that complicates the assumption that VR can fully substitute for in-vivo exposure assessment. For clinicians using VR with SAD clients, the takeaway is that VR is a workable but partial substitute for in-vivo exposure - useful for graded exposure and engagement, less reliable for full-intensity physiological elicitation.
Key findings
- Within-subjects design with 21 SAD adults + 24 non-anxious controls; each participant gave an impromptu speech in front of both an in-vivo (live) audience AND a VR audience
- VR task elicited SIGNIFICANT increases in heart rate, electrodermal activity, respiratory sinus arrhythmia, and self-reported distress OVER BASELINE - confirming that VR public-speaking generates measurable arousal
- VR task was LESS anxiety-producing than the IN-VIVO task on physiological + subjective measures - in-vivo exposure produces a stronger response than VR exposure at matched task structure
- Participants reported MODERATE presence in VR - but significantly LESS than in-vivo presence ratings - sense of being-there is partial, not complete
- NO significant SAD-vs-control group differences emerged on physiological measures in VR - the expected pattern (greater arousal in SAD than controls) was NOT observed in this paradigm
- The dissociation: VR can elicit distress at the within-subject level (above baseline) but does NOT discriminate SAD from non-anxious controls on physiology in this specific design
- Pre-2015 era VR research-grade hardware; contemporary consumer HMDs may produce different presence and physiological profiles
- Beidel co-author connection: also co-author of Wong Sarver 2014 (childhood SAD VR feasibility) - this is the Beidel-group's adult-SAD validity work
Background
By 2014-2015, VR was being widely proposed as a clinical exposure modality for social anxiety disorder, but a key validity question remained underexplored: does VR public-speaking actually elicit the physiological and subjective distress patterns that characterise SAD in vivo? Without this realism-and-validity foundation, claims about VR’s clinical utility for SAD assessment and treatment would rest on assumption rather than evidence.
What they did and found
Within-subjects design. 21 SAD adults + 24 non-anxious controls each gave an impromptu speech in front of both an in-vivo audience and a VR audience. Outcomes: HR, EDA, RSA, self-reported distress, sense of presence.
- VR vs baseline: significant increases in HR, EDA, RSA, distress - VR public-speaking generates measurable arousal.
- VR vs in-vivo: in-vivo produced stronger response - VR is attenuated relative to in-vivo.
- Presence in VR: moderate but less than in-vivo.
- SAD vs control in VR: NO significant physiological group differences emerged - a discriminant-validity caution.
Why it matters + Limitations
VR is a workable but partial substitute for in-vivo exposure assessment in SAD. Useful for graded exposure / engagement-building; less reliable for full-intensity physiological elicitation or for discriminating clinical from non-clinical responders on physiology alone. Limitations: era-appropriate research-grade hardware (2014-2015); contemporary consumer HMDs may differ; the null SAD-vs-control finding may reflect power and paradigm rather than true equivalence.
Implications for practice
For clinicians using or considering VR with SAD clients, this study delivers an important nuance: VR DOES elicit distress over baseline (a prerequisite for clinical use) but the response is attenuated relative to in-vivo public speaking. VR is a workable but PARTIAL substitute for in-vivo exposure. For graded exposure and engagement-building, VR offers a controlled lower-intensity environment that may be useful early in a treatment hierarchy. For full-intensity physiological elicitation (e.g., where the goal is maximally activating the fear network), in-vivo exposure remains the gold standard. For PWS with SAD comorbidity, this study's findings argue for blended VR + in-vivo protocols rather than VR-only substitution. The null SAD-vs-control physiology finding is worth flagging as a discriminant-validity caution: VR may not reliably differentiate clinical from non-clinical responders on physiology alone.
Cite this study
If you reference this study in your work, the canonical citation formats are:
@article{owens2015,
author = {Owens, M. E. and Beidel, D. C.},
title = {Can Virtual Reality Effectively Elicit Distress Associated with Social Anxiety Disorder?},
journal = {Journal of Psychopathology and Behavioral Assessment},
year = {2015},
doi = {10.1007/s10862-014-9454-x},
url = {https://withvr.app/evidence/studies/owens-2015}
}TY - JOUR
AU - Owens, M. E.
AU - Beidel, D. C.
TI - Can Virtual Reality Effectively Elicit Distress Associated with Social Anxiety Disorder?
JO - Journal of Psychopathology and Behavioral Assessment
PY - 2015
DO - 10.1007/s10862-014-9454-x
UR - https://withvr.app/evidence/studies/owens-2015
ER - Know of research that should be in this hub? If a relevant peer-reviewed study is not listed here, send the reference to hello@withvr.app. The hub is kept up to date as the literature grows.
Funding & independence
Affiliations: lead authors Owens and Beidel at University of Central Florida (Beidel is established SAD/anxiety researcher and co-author of Wong Sarver 2014). Specific funding sources reported in published article. Peer-reviewed in Journal of Psychopathology and Behavioral Assessment (Springer). No withVR BV involvement. Summary prepared independently by withVR. The VR system used was era-appropriate research configuration, NOT Therapy withVR or Research withVR.